| Literature DB >> 35733182 |
Joanna McLaughlin1, Lauren J Scott2,3, Lucie Owens4, Hugh McLeod2,3, Carlos Sillero-Rejon2,3, Rebecca Reynolds5, Amanda Owen-Smith2,3, Elizabeth M Hill2,3, Russell Jago3,6, Jenny L Donovan2, Sabi Redwood2,3, Ruth Kipping2.
Abstract
BACKGROUND: Health optimisation programmes are increasingly popular and aim to support patients to lose weight or stop smoking ahead of surgery, yet there is little published evidence about their impact. This study aimed to assess the feasibility of evaluating a programme introduced by a National Health Service (NHS) clinical commissioning group offering support to smokers/obese patients in an extra 3 months prior to the elective hip/knee surgery pathway.Entities:
Keywords: Elective surgery; Health optimisation; Obesity; Prehabilitation; Smoking
Year: 2022 PMID: 35733182 PMCID: PMC9219203 DOI: 10.1186/s13741-022-00255-2
Source DB: PubMed Journal: Perioper Med (Lond) ISSN: 2047-0525
Fig. 1The hip and knee pathway for health optimisation and non-health optimisation patients. Note: Non-health optimisation patients proceed immediately from the initial Hip and Knee team appointment to the 6-week ‘standard’ hip and knee pathway
Baseline information by patient group (health optimisation and non-health optimisation)
| Non-health optimisation pathway | Health optimisation pathway | |||||||
|---|---|---|---|---|---|---|---|---|
| Accepted referral to Healthy Lifestyles Service | Did not accept referral to Healthy Lifestyles Service | All health optimisation patients (accepted referral & did not accept referral combined) | ||||||
| ( | ( | ( | ( | |||||
| Female | 195 | 61.3% | 36 | 70.6% | 79 | 59.4% | 115 | 62.5% |
| Male | 123 | 38.7% | 15 | 29.4% | 54 | 40.6% | 69 | 37.5% |
| Median, IQR | 72 | (66, 79) | 67 | (58, 74) | 70 | (63, 75) | 70 | (62, 75) |
| 1 (most deprived) | 10 | 3.1% | 3 | 5.9% | 11 | 8.3% | 14 | 7.6% |
| 2 | 23 | 7.2% | 10 | 19.6% | 8 | 6.0% | 18 | 9.8% |
| 3 | 34 | 10.7% | 8 | 15.7% | 29 | 21.8% | 37 | 20.1% |
| 4 | 120 | 37.7% | 20 | 39.2% | 42 | 31.6% | 62 | 33.7% |
| 5 (least deprived) | 131 | 41.2% | 10 | 19.6% | 43 | 32.3% | 53 | 28.8% |
| Hip | 133 | 41.8% | 15 | 29.4% | 34 | 25.6% | 49 | 26.6% |
| Knee | 185 | 58.2% | 36 | 70.6% | 99 | 74.4% | 135 | 73.4% |
| Smoker | 5 | 1.6% | 8 | 15.7% | 12 | 9.0% | 20 | 10.9% |
| Non-smoker | 297 | 93.4% | 41 | 80.4% | 118 | 88.7% | 159 | 86.4% |
| Missing | 16 | 5.0% | 2 | 3.9% | 3 | 2.3% | 5 | 2.7% |
| < 18: underweight | 1 | 0.3% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
| 18–24: healthy weight | 99 | 31.1% | 1 | 2.0% | 3 | 2.3% | 4 | 2.2% |
| 25–29: overweight | 192 | 60.4% | 0 | 0.0% | 11 | 8.3% | 11 | 6.0% |
| 30+: obese | 9 | 2.8% | 50 | 98.0% | 117 | 88.0% | 167 | 90.8% |
| Missing | 17 | 5.3% | 0 | 0.0% | 2 | 1.5% | 2 | 1.1% |
| Median, IQR a | 26.0 | (24.0, 28.0) | 35.0 | (32.0, 38.2) | 33.0 | (31.0, 35.6) | 33.2 | (31.4, 36.3) |
| 0–19: severe | 158 | 49.7% | 37 | 72.5% | 80 | 60.2% | 117 | 63.6% |
| 20–29: moderate | 149 | 46.9% | 13 | 25.5% | 50 | 37.6% | 63 | 34.2% |
| 30–39: mild | 6 | 1.9% | 0 | 0.0% | 2 | 1.5% | 2 | 1.1% |
| 40–48: normal | 0 | 0.0% | 0 | 0.0% | 1 | 0.8% | 1 | 0.5% |
| Missing | 5 | 1.6% | 1 | 2.0% | 0 | 0.0% | 1 | 0.5% |
| Median, IQR * | 19 | (15, 24) | 14 | (11, 20) | 17 | (12, 22) | 16 | (12, 21) |
BMI body mass index, IQR interquartile range
aFor those patients without missing data
Patient outcomes by group for all patients referred into the Hip and Knee pathway: surgery or self-management
| Non-health optimisation pathwaya | Health optimisation pathwaya | |||||||
|---|---|---|---|---|---|---|---|---|
| Accepted | Did not accept referral to Healthy Lifestyles Service | All health optimisation patients (accepted referral & did not accept referral combined) | ||||||
| ( | ( | ( | ( | |||||
| 179 | 56.3% | 25 | 49.0% | 81 | 60.9% | 106 | 57.6% | |
| Completed physiotherapy | 155 | 86.6% | 88 | 83.0% | ||||
| 103 | 32.4% | 17 | 33.3% | 31 | 23.3% | 48 | 26.1% | |
| Completed physiotherapy | 94 | 91.3% | 37 | 77.1% | ||||
| 36 | 11.3% | 9 | 17.6% | 21 | 15.8% | 30 | 16.3% | |
| Never joined the pathway | 22 | 6.9% | 13 | 7.1% | ||||
| Dropped out of pathway | 9 | 2.8% | 14 | 7.6% | ||||
| Still in the pathway | 4 | 1.3% | 2 | 1.1% | ||||
| Died | 1 | 0.3% | 1 | 0.5% | ||||
| Duration of physiotherapy (months)b, median (IQR) | 1.8 | (1.5, 2.3) | 4.1 | (3.8, 4.4) | 3.7 | (1.8, 4.1) | 3.9 | (2.1, 4.2) |
| Length of hospital stay (days)c, median (IQR) | 3 | (2, 3) | 3 | (2,4) | ||||
a249/318 (78.3%) on the non-health optimisation and 125/184 (67.9%) on the health optimisation ‘completed’ the pathways (attended the core physiotherapy element and a final assessment appointment)
bFrom initial assessment to follow-up appointment for patients who completed physiotherapy
cFor patients who went on to be admitted for surgery during the follow-up period
Patient outcomes by group for those who completed the physiotherapy pathway: BMI and Oxford scores
| Non-health optimisation pathway | Health optimisation pathway | |||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Accepted referral to Healthy Lifestyles Service | Did not accept referral to Healthy Lifestyles Service | All health optimisation patients (accepted referral & did not accept referral combined) | ||||||||||||||
| Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | Baseline | Follow-up | |||||||||
| < 18: underweight | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
| 18–24: healthy weight | 72 | 28.9% | 34 | 13.7% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% |
| 25–29: overweight | 163 | 65.5% | 72 | 28.9% | 0 | 0.0% | 3 | 8.8% | 8 | 8.8% | 13 | 14.3% | 8 | 6.4% | 16 | 12.8% |
| 30+: obese | 6 | 2.4% | 5 | 2.0% | 34 | 100.0% | 20 | 58.8% | 81 | 89.0% | 49 | 53.8% | 115 | 92.0% | 69 | 55.2% |
| Missing | 8 | 3.2% | 138 | 55.4% | 0 | 0.0% | 11 | 32.4% | 2 | 2.2% | 29 | 31.9% | 2 | 1.6% | 40 | 32.0% |
| Median, IQR* | 26.0 | (24.0, 28.0) | 26.0 | (24.0, 28.4) | 34.8 | (32.0, 38.2) | 34.0 | (31.0, 38.0) | 33.0 | (31.0, 36.3) | 32.0 | (30.0, 35.6) | 33.2 | (31.4, 37.0) | 32.1 | (30.0, 36.4) |
| Change in BMI | 0.0 | (0.0, 0.0) | − 1.8 | (− 3.9, − 0.5) | − 0.5 | (− 1.8, 0.0) | − 0.8 | (− 2.4, 0.0) | ||||||||
| 0–19: severe | 123 | 49.4% | 87 | 34.9% | 23 | 67.60% | 15 | 44.1% | 56 | 61.5% | 44 | 48.4% | 79 | 63.2% | 59 | 47.2% |
| 20–29: moderate | 122 | 49.0% | 88 | 35.3% | 11 | 32.4% | 13 | 38.2% | 34 | 37.4% | 31 | 34.1% | 45 | 36.0% | 44 | 35.2% |
| 30–39: mild | 4 | 1.6% | 51 | 20.5% | 0 | 0.0% | 3 | 8.8% | 1 | 1.1% | 12 | 13.2% | 1 | 0.8% | 15 | 12.0% |
| 40–48: normal | 0 | 0.0% | 10 | 4.0% | 0 | 0.0% | 0 | 0.0% | 0 | 0.0% | 1 | 1.1% | 0 | 0.0% | 1 | 0.8% |
| Missing | 0 | 0.0% | 13 | 5.2% | 0 | 0.0% | 3 | 8.8% | 0 | 0.0% | 3 | 3.3% | 0 | 0.0% | 6 | 4.8% |
| Median, IQR* | 20 | (15, 25) | 23 | (17, 30) | 16 | (11, 21) | 21 | (13, 25) | 18 | (13, 22) | 20 | (13, 25) | 17 | (12, 21) | 20 | (13, 25) |
| Change in Oxford score | 3 | (− 1, 8) | 1 | (− 3, 8) | 1 | (− 2, 7) | 1 | (− 2, 7) | ||||||||
BMI body mass index, IQR interquartile range
aFor those patients without missing data